ArticleJMIR formative research2026
Quality Evaluation Using the Mobile App Rating Scale for Speech Therapy in Parkinson Disease: Systematic Search and Evaluation.
Article in JMIR formative research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: As the global population ages, Parkinson disease (PD) has emerged as the second most prevalent neurodegenerative condition after Alzheimer disease. People with PD often experience speech problems, including reduced volume, monotone pitch, breathiness, and word slurring. Interventions such as speech therapy through mobile apps provide reassurance and easier access to care for patients having this neurodegenerative condition. Mobile apps offer patients with PD greater access to care and the reassurance of being able to manage their condition at home. However, we do not know the quality of these apps. A systematic evaluation of these mobile apps is necessary to ensure their effectiveness and suitability for use by patients with PD. Objective: This study aimed to evaluate the quality of existing free apps that support speech therapy for people with PD. Methods: This study took place at Weill Cornell Medicine in New York, New York. It was conducted between January 2024 and July 2025. We conducted a systematic application search to identify apps available on the Apple App Store for speech therapy targeting people with PD and then performed an evaluation using the Mobile App Rating Scale framework with 4 raters. We only included freely available apps. We calculated interrater reliability and found median and mean ratings and SD for Mobile App Rating Scale dimensions. Results: From 33 candidate apps, we included 3 apps in our evaluation. Functionality scored high for all 3 apps, with ratings above 4.5. However, engagement scored the lowest in all the apps. Interrater reliability agreement varied for all sections. Conclusions: All 3 apps offer targeted exercises and are targeted for the patient. Mobile apps hold promise for increasing the accessibility of speech therapy for patients with PD and provide promising support for managing speech difficulties in PD. Evaluating these apps is essential to determine their quality in supporting these patients. Future research with speech therapy apps should evaluate clinical efficacy through randomized controlled trials.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.